Literature DB >> 7752808

Chromosomal localization of opioid peptide and receptor genes in the mouse.

B Giros1, M Pohl, J M Rochelle, M F Seldin.   

Abstract

Opiate receptors are the primary targets for the drugs of abuse morphine and heroin. In this study, we completed the localization on mouse chromosomes of the genes encoding mu (Oprm) and kappa (Oprk) receptors, as well as the genes for the opioid propeptides proenkephalin (Penk) and prodynorphin (Pdyn). The genetic mapping was performed using a panel of DNA samples from an interspecific cross [C3H/HeJ-gld and (C3H/HeJ-gld x Mus spretus)F1] that has been characterized for more than 800 markers throughout the genome. The genes are localized on mouse Chr 1 (Oprk, 10 cM from the centromere), Chr 2 (Pdyn, 75 cM from the centromere), Chr 4 (Penk, 1 cM from the centromere) and Chr 10 (Oprm, 10 cM from the centromere). Interestingly, the gene for the mu receptor is located in the same region as a Quantitative Trait Locus for high morphine consumption, thus raising the possibility of its direct role in drug abuse mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752808     DOI: 10.1016/0024-3205(95)00119-q

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  15 in total

Review 1.  Transcriptional and epigenetic regulation of opioid receptor genes: present and future.

Authors:  Li-Na Wei; Horace H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

Review 2.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 3.  Current research on opioid receptor function.

Authors:  Yuan Feng; Xiaozhou He; Yilin Yang; Dongman Chao; Lawrence H Lazarus; Ying Xia
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

Review 4.  The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.

Authors:  Martin L Dalefield; Brittany Scouller; Rabia Bibi; Bronwyn M Kivell
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

5.  Involvement of the melanocortin-1 receptor in acute pain and pain of inflammatory but not neuropathic origin.

Authors:  Ada Delaney; Margaret Keighren; Susan M Fleetwood-Walker; Ian J Jackson
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

6.  Analysis of candidate genes for morphine preference quantitative trait locus Mop2.

Authors:  G A Doyle; C L Schwebel; S E Ruiz; A D Chou; A T Lai; M-J Wang; G G Smith; R J Buono; W H Berrettini; T N Ferraro
Journal:  Neuroscience       Date:  2014-07-22       Impact factor: 3.590

7.  Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.

Authors:  Glenn A Doyle; X Rebecca Sheng; Sharon S J Lin; Danielle M Press; Dorothy E Grice; Russell J Buono; Thomas N Ferraro; Wade H Berrettini
Journal:  Gene       Date:  2007-02-20       Impact factor: 3.688

8.  Genetic analysis of the murine mu opioid receptor: increased complexity of Oprm gene splicing.

Authors:  Tor-Morten Kvam; Cecilie Baar; Trude T Rakvåg; Stein Kaasa; Hans E Krokan; Frank Skorpen
Journal:  J Mol Med (Berl)       Date:  2004-01-09       Impact factor: 4.599

9.  Morphine regulates expression of μ-opioid receptor MOR-1A, an intron-retention carboxyl terminal splice variant of the μ-opioid receptor (OPRM1) gene via miR-103/miR-107.

Authors:  Zhigang Lu; Jin Xu; Mingming Xu; Gavril W Pasternak; Ying-Xian Pan
Journal:  Mol Pharmacol       Date:  2013-12-03       Impact factor: 4.436

10.  Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P.

Authors:  Jin Xu; Mingming Xu; Elizabeth Bolan; Annie-Kim Gilbert; Gavril W Pasternak; Ying-Xian Pan
Journal:  Synapse       Date:  2014-01-16       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.